Program Affiliation Cont... CTU
Date
Title
Status
All
Completed
Current
Soon to Launch
Program Affiliation
All
Global TA
PHIA
QICIP
CQUIN
GNCBP
OpCon
OPTIMIZE
HPTN
MTCT-Plus
MCAP
UTAP
TRACE
COVID
CTU
Project Location
All
Tajikistan
Brazil
Guatemala
Georgia
Haiti
China
Kazakhstan
Kyrgyzstan
Namibia
Nigeria
Rwanda
Central Asia
Burundi
Liberia
Philippines
Senegal
Panama
Honduras
El Salvador
Harlem
Bronx
Colombia & Peru
Tanzania
Angola
Cameroon
Côte d’Ivoire
Democratic Republic of the Congo
Lesotho
Kenya
Ethiopia
Malawi
Sierra Leone
Zimbabwe
Mozambique
Eswatini
South Sudan
Mali
South Africa
Uganda
Zambia
United States
Ukraine
Myanmar
june
Project Details
The UBUNTU study is a research study evaluating the Moderna COVID-19 mRNA vaccine. We already know that this vaccine prevents COVID-19 disease, including severe COVID-19. The United States and many
Project Details
Web link: https://www.coronaviruspreventionnetwork.org/ubuntu-vaccine-research-study
A Randomized Non-Inferiority Study
Project Details
Soon to Launch A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults
Project Details
Project Details
A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. https://icap.columbia.edu/where-we-work/icap-ctu/
Project Details
https://icap.columbia.edu/where-we-work/icap-ctu/
july
Project Details
The UBUNTU study is a research study evaluating the Moderna COVID-19 mRNA vaccine. We already know that this vaccine prevents COVID-19 disease, including severe COVID-19. The United States and many
Project Details
Web link: https://www.coronaviruspreventionnetwork.org/ubuntu-vaccine-research-study
A Randomized Non-Inferiority Study
Project Details
Soon to Launch A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults
Project Details
Project Details
A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. https://icap.columbia.edu/where-we-work/icap-ctu/
Project Details
https://icap.columbia.edu/where-we-work/icap-ctu/
august
Project Details
The UBUNTU study is a research study evaluating the Moderna COVID-19 mRNA vaccine. We already know that this vaccine prevents COVID-19 disease, including severe COVID-19. The United States and many
Project Details
Web link: https://www.coronaviruspreventionnetwork.org/ubuntu-vaccine-research-study
A Randomized Non-Inferiority Study
Project Details
Soon to Launch A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults
Project Details
Project Details
A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. https://icap.columbia.edu/where-we-work/icap-ctu/
Project Details
https://icap.columbia.edu/where-we-work/icap-ctu/
september
Project Details
The UBUNTU study is a research study evaluating the Moderna COVID-19 mRNA vaccine. We already know that this vaccine prevents COVID-19 disease, including severe COVID-19. The United States and many
Project Details
Web link: https://www.coronaviruspreventionnetwork.org/ubuntu-vaccine-research-study
A Randomized Non-Inferiority Study
Project Details
Soon to Launch A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults
Project Details
Project Details
A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. https://icap.columbia.edu/where-we-work/icap-ctu/
Project Details
https://icap.columbia.edu/where-we-work/icap-ctu/
october
Project Details
The UBUNTU study is a research study evaluating the Moderna COVID-19 mRNA vaccine. We already know that this vaccine prevents COVID-19 disease, including severe COVID-19. The United States and many
Project Details
Web link: https://www.coronaviruspreventionnetwork.org/ubuntu-vaccine-research-study
A Randomized Non-Inferiority Study
Project Details
Soon to Launch A Randomized Non-Inferiority Study to Assess Immunogenicity, Safety, and Acceptability of Two vs. Three Doses of the Nonavalent Human Papillomavirus (HPV) Vaccine Among Children, Adolescents and Young Adults
Project Details
Project Details
A Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Pre-Exposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection. https://icap.columbia.edu/where-we-work/icap-ctu/
Project Details
https://icap.columbia.edu/where-we-work/icap-ctu/